Alejandro Enriquez-Marulanda, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intracranial Aneurysm | 35 | 2025 | 1293 | 5.790 |
Why?
|
Embolization, Therapeutic | 32 | 2024 | 1410 | 5.020 |
Why?
|
Hematoma, Subdural, Chronic | 6 | 2024 | 98 | 1.980 |
Why?
|
Subarachnoid Hemorrhage | 13 | 2025 | 1039 | 1.480 |
Why?
|
Endovascular Procedures | 20 | 2025 | 2218 | 1.460 |
Why?
|
Aneurysm, Ruptured | 5 | 2023 | 462 | 1.450 |
Why?
|
Cerebral Revascularization | 4 | 2024 | 263 | 1.330 |
Why?
|
Thromboembolism | 9 | 2024 | 1004 | 1.290 |
Why?
|
Platelet Function Tests | 4 | 2024 | 275 | 1.270 |
Why?
|
Carotid Artery Diseases | 3 | 2023 | 878 | 1.070 |
Why?
|
Stents | 14 | 2024 | 3200 | 0.960 |
Why?
|
Posterior Cerebral Artery | 2 | 2024 | 35 | 0.860 |
Why?
|
Platelet Aggregation | 2 | 2024 | 769 | 0.850 |
Why?
|
Carotid Artery, Internal | 4 | 2024 | 445 | 0.790 |
Why?
|
Ventriculostomy | 3 | 2021 | 132 | 0.770 |
Why?
|
Platelet Aggregation Inhibitors | 9 | 2025 | 2763 | 0.750 |
Why?
|
Craniotomy | 3 | 2024 | 747 | 0.690 |
Why?
|
Aneurysm | 2 | 2023 | 343 | 0.670 |
Why?
|
Intracranial Hypertension | 2 | 2022 | 193 | 0.670 |
Why?
|
Drainage | 4 | 2024 | 1184 | 0.610 |
Why?
|
Paraneoplastic Cerebellar Degeneration | 1 | 2018 | 13 | 0.600 |
Why?
|
Drug Resistance | 1 | 2024 | 1599 | 0.600 |
Why?
|
Toxoplasmosis, Cerebral | 1 | 2017 | 19 | 0.580 |
Why?
|
Cranial Fossa, Posterior | 1 | 2018 | 134 | 0.570 |
Why?
|
Moyamoya Disease | 3 | 2024 | 274 | 0.540 |
Why?
|
Brain Stem Infarctions | 1 | 2016 | 31 | 0.540 |
Why?
|
Methanol | 1 | 2017 | 91 | 0.540 |
Why?
|
Physician Assistants | 1 | 2018 | 190 | 0.530 |
Why?
|
Meningeal Arteries | 5 | 2022 | 66 | 0.530 |
Why?
|
Retrospective Studies | 54 | 2025 | 81903 | 0.510 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2016 | 113 | 0.500 |
Why?
|
Aspirin | 3 | 2024 | 3135 | 0.500 |
Why?
|
Nurse Practitioners | 1 | 2018 | 271 | 0.500 |
Why?
|
Pons | 1 | 2016 | 242 | 0.500 |
Why?
|
Blood Vessel Prosthesis | 7 | 2023 | 957 | 0.490 |
Why?
|
Temporal Arteries | 3 | 2024 | 155 | 0.480 |
Why?
|
Parkinsonian Disorders | 1 | 2017 | 285 | 0.440 |
Why?
|
Dystonic Disorders | 1 | 2018 | 354 | 0.430 |
Why?
|
Propensity Score | 6 | 2024 | 1968 | 0.430 |
Why?
|
Treatment Outcome | 37 | 2024 | 65480 | 0.430 |
Why?
|
Central Nervous System Vascular Malformations | 3 | 2019 | 142 | 0.420 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1176 | 0.390 |
Why?
|
Carotid-Cavernous Sinus Fistula | 2 | 2023 | 35 | 0.370 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 877 | 0.370 |
Why?
|
Thrombectomy | 3 | 2021 | 675 | 0.360 |
Why?
|
Angiography, Digital Subtraction | 4 | 2019 | 332 | 0.360 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2018 | 1093 | 0.350 |
Why?
|
Off-Label Use | 2 | 2022 | 185 | 0.350 |
Why?
|
Hydrocephalus | 4 | 2022 | 770 | 0.340 |
Why?
|
Neurosurgical Procedures | 5 | 2024 | 2110 | 0.330 |
Why?
|
Deep Brain Stimulation | 1 | 2018 | 851 | 0.330 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2024 | 366 | 0.320 |
Why?
|
Neuroma, Acoustic | 2 | 2024 | 458 | 0.310 |
Why?
|
Collateral Circulation | 3 | 2024 | 291 | 0.300 |
Why?
|
Ventriculoperitoneal Shunt | 3 | 2020 | 187 | 0.300 |
Why?
|
Humans | 80 | 2025 | 768970 | 0.280 |
Why?
|
Middle Aged | 47 | 2025 | 223737 | 0.280 |
Why?
|
Intracranial Hemorrhages | 2 | 2025 | 811 | 0.270 |
Why?
|
Cerebral Angiography | 5 | 2024 | 1272 | 0.260 |
Why?
|
Aged | 41 | 2025 | 171786 | 0.250 |
Why?
|
Postoperative Complications | 8 | 2025 | 15889 | 0.240 |
Why?
|
Female | 53 | 2025 | 397515 | 0.240 |
Why?
|
Radiosurgery | 2 | 2024 | 1346 | 0.240 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4207 | 0.230 |
Why?
|
Anterior Cerebral Artery | 1 | 2024 | 50 | 0.230 |
Why?
|
Male | 49 | 2025 | 365203 | 0.220 |
Why?
|
Trigeminal Neuralgia | 1 | 2024 | 105 | 0.220 |
Why?
|
United States Food and Drug Administration | 2 | 2022 | 1672 | 0.220 |
Why?
|
Cerebrospinal Fluid Shunts | 2 | 2022 | 197 | 0.220 |
Why?
|
Retreatment | 1 | 2024 | 600 | 0.210 |
Why?
|
Wounds, Gunshot | 2 | 2018 | 588 | 0.190 |
Why?
|
Papilledema | 1 | 2022 | 130 | 0.180 |
Why?
|
Pseudotumor Cerebri | 1 | 2022 | 107 | 0.180 |
Why?
|
Surgical Stapling | 1 | 2021 | 99 | 0.180 |
Why?
|
Adult | 31 | 2025 | 223851 | 0.170 |
Why?
|
Tissue Plasminogen Activator | 3 | 2020 | 1165 | 0.170 |
Why?
|
Head | 2 | 2022 | 927 | 0.160 |
Why?
|
Vasospasm, Intracranial | 1 | 2021 | 214 | 0.160 |
Why?
|
Transverse Sinuses | 1 | 2019 | 25 | 0.160 |
Why?
|
Sutures | 1 | 2021 | 283 | 0.160 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2019 | 58 | 0.160 |
Why?
|
Vertebral Artery | 1 | 2020 | 185 | 0.160 |
Why?
|
Cavernous Sinus | 1 | 2019 | 122 | 0.150 |
Why?
|
Catheters | 1 | 2021 | 427 | 0.150 |
Why?
|
Magnetic Resonance Angiography | 3 | 2019 | 1434 | 0.150 |
Why?
|
Cohort Studies | 14 | 2024 | 41808 | 0.150 |
Why?
|
Neurosurgery | 1 | 2024 | 690 | 0.140 |
Why?
|
Polyvinyls | 1 | 2017 | 156 | 0.140 |
Why?
|
Hearing Loss | 2 | 2024 | 785 | 0.140 |
Why?
|
Arteriovenous Fistula | 1 | 2020 | 320 | 0.140 |
Why?
|
Dimethyl Sulfoxide | 1 | 2017 | 251 | 0.130 |
Why?
|
Follow-Up Studies | 10 | 2024 | 39394 | 0.130 |
Why?
|
Sodium | 1 | 2021 | 1597 | 0.130 |
Why?
|
Basal Ganglia | 1 | 2019 | 555 | 0.130 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2020 | 465 | 0.130 |
Why?
|
Forecasting | 1 | 2024 | 2945 | 0.120 |
Why?
|
Cerebral Infarction | 1 | 2020 | 975 | 0.120 |
Why?
|
Meningioma | 1 | 2023 | 1226 | 0.120 |
Why?
|
Hypotension | 1 | 2020 | 888 | 0.120 |
Why?
|
Meningeal Neoplasms | 1 | 2023 | 1258 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3253 | 0.110 |
Why?
|
Catheterization | 1 | 2019 | 1431 | 0.110 |
Why?
|
Ticlopidine | 1 | 2018 | 730 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5892 | 0.100 |
Why?
|
Metformin | 1 | 2020 | 909 | 0.100 |
Why?
|
Cerebrovascular Circulation | 2 | 2021 | 2734 | 0.100 |
Why?
|
Glasgow Coma Scale | 3 | 2018 | 579 | 0.100 |
Why?
|
Diabetes Complications | 1 | 2018 | 1320 | 0.090 |
Why?
|
Patient Transfer | 1 | 2018 | 792 | 0.090 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5544 | 0.090 |
Why?
|
Seizures | 1 | 2024 | 3000 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2055 | 0.090 |
Why?
|
Students, Medical | 1 | 2024 | 1964 | 0.090 |
Why?
|
CD4 Lymphocyte Count | 1 | 2017 | 2598 | 0.090 |
Why?
|
Curriculum | 1 | 2024 | 3782 | 0.090 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21188 | 0.090 |
Why?
|
Prospective Studies | 5 | 2023 | 54962 | 0.080 |
Why?
|
Hearing | 2 | 2024 | 505 | 0.080 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2018 | 1459 | 0.080 |
Why?
|
Blood Pressure | 3 | 2020 | 8544 | 0.070 |
Why?
|
Acute Disease | 1 | 2018 | 7245 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2008 | 0.070 |
Why?
|
Aged, 80 and over | 9 | 2024 | 59739 | 0.070 |
Why?
|
Stroke | 2 | 2020 | 9756 | 0.070 |
Why?
|
Colombia | 2 | 2018 | 287 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2020 | 3008 | 0.070 |
Why?
|
Microsurgery | 2 | 2024 | 803 | 0.070 |
Why?
|
Fibrinolytic Agents | 3 | 2020 | 2080 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3491 | 0.060 |
Why?
|
Trephining | 1 | 2024 | 18 | 0.060 |
Why?
|
United States | 2 | 2022 | 73186 | 0.060 |
Why?
|
Statistics, Nonparametric | 2 | 2018 | 2862 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13510 | 0.050 |
Why?
|
Young Adult | 6 | 2024 | 60131 | 0.050 |
Why?
|
Multiple Sclerosis | 1 | 2017 | 3250 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13021 | 0.050 |
Why?
|
Brain | 2 | 2020 | 27453 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6214 | 0.050 |
Why?
|
Orbit | 1 | 2024 | 459 | 0.050 |
Why?
|
Learning Curve | 1 | 2022 | 232 | 0.040 |
Why?
|
Watchful Waiting | 1 | 2024 | 498 | 0.040 |
Why?
|
Reperfusion | 1 | 2021 | 266 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15471 | 0.040 |
Why?
|
Adolescent | 6 | 2024 | 89244 | 0.040 |
Why?
|
Compassionate Use Trials | 1 | 2017 | 50 | 0.040 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2018 | 172 | 0.040 |
Why?
|
Accidents | 1 | 2018 | 164 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 26395 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36854 | 0.030 |
Why?
|
Independent Living | 1 | 2021 | 584 | 0.030 |
Why?
|
Carotid Arteries | 1 | 2021 | 943 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2020 | 646 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2022 | 1445 | 0.030 |
Why?
|
APACHE | 1 | 2017 | 268 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2483 | 0.030 |
Why?
|
Child | 3 | 2022 | 80960 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2018 | 848 | 0.030 |
Why?
|
Risk | 2 | 2018 | 9621 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2024 | 1515 | 0.030 |
Why?
|
Risk Factors | 4 | 2025 | 74976 | 0.030 |
Why?
|
Thrombophilia | 1 | 2018 | 308 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1104 | 0.030 |
Why?
|
California | 1 | 2019 | 1443 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2018 | 1049 | 0.030 |
Why?
|
Headache | 1 | 2022 | 1264 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2018 | 1209 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1757 | 0.030 |
Why?
|
Hospitals, General | 1 | 2017 | 810 | 0.020 |
Why?
|
Self-Injurious Behavior | 1 | 2018 | 568 | 0.020 |
Why?
|
Violence | 1 | 2018 | 936 | 0.020 |
Why?
|
Spinal Cord | 1 | 2020 | 1813 | 0.020 |
Why?
|
Emergencies | 1 | 2018 | 1221 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2017 | 2360 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20776 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2020 | 2660 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2018 | 1924 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 30046 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9684 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2831 | 0.020 |
Why?
|
Reoperation | 1 | 2017 | 4342 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14752 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13318 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10765 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10115 | 0.020 |
Why?
|
Internship and Residency | 1 | 2024 | 5956 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2017 | 3800 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 40261 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8094 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15951 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14201 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36556 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42683 | 0.010 |
Why?
|